BackEikon Therapeutics Common Stock Overview

Eikon Therapeutics Common Stock Total Current Liabilities

Track Eikon Therapeutics Common Stock's total current liabilities ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$45.06M

Peer average

Loading

Eikon Therapeutics Common Stock Total Current Liabilities History

Loading

Eikon Therapeutics Common Stock vs. peers: Total Current Liabilities Comparison

Loading

Eikon Therapeutics Common Stock Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Eikon Therapeutics Common Stock (EIKN) FAQ

The latest total current liabilities for EIKN is $45M as of March 2026. Investors often review this figure alongside Eikon Therapeutics Common Stock's historical trend and sector peers before judging valuation or financial health.

A total current liabilities figure of $45M for EIKN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EIKN's total current liabilities ($45M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Eikon Therapeutics Common Stock's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.